2017 - CGH Spotlight Blog
-
-
-
-
New Lancet Oncology publication - Defining a research and policy agenda for betel quid and areca nutBetel quid and areca nut, typically made up of a mixture of areca nut and slaked lime wrapped in a betel leaf with added flavorings, is a known risk factor for many oral and other associated cancers. There are more than 600 million betel quid or areca nut users worldwide (or 10% of the world’s population), making it a critical global cancer control issue. With its use steeped in culture and tradition, the use of betel quid and areca nut is widely unregulated, and poses a significant and understudied health threat to the Asia-Pacific region where prevalence is high. Unlike many forms of smoked tobacco, the two are widely used by women in regions where common. Betel quid and areca use also extends beyond the Asia-Pacific region to diaspora and migrant communities in the U.S., South Africa, and parts of Europe and the Middle East.
-
Engaging Brazilian Partners in Collaborative Cancer ResearchCGH engages with Brazilian partners to further collaborative cancer research projects.
-
HIV and Cancer Interaction Highlights Need to Address Disease StigmaThe global landscape of disease highlights disparities that exist between nations. An estimated 36 million people worldwide live with HIV and AIDS, of which only 1 million are located within the United States. While the diagnosis of a life-threatening disease can be devastating, individuals with HIV and AIDS frequently bear an additional burden of stigma and discrimination.
-
Addressing the Global Burden of Breast CancerThe US National Cancer Institute’s Center for Global Health (CGH) has been a key partner in a multi-institutional expert team that has developed a set of publications to address foundational concerns in breast cancer care across the cancer care continuum and within limited resource settings.
-
Why I Do Cancer ResearchWorld Cancer Research Day is recognized on September 24, 2017. This day presents an opportunity for all of us to remind the world of the critically important roles research and cancer researchers play in reducing the global burden of cancer. Together with ten other global partners, NCI participated in the planning and launch of this initiative, highlighting the amplified impact of international cooperation in the clinical research arena.
-
Working with India to Advance Cancer ResearchCGH visits India to further develop our collaboration in cancer research.
-
NCI supports 10 New Bilateral Collaborative Research Partnerships on CancerThe Center for Global Health works with foreign scientific funding agencies to incentivize cooperation on work that is of importance to the American cancer research enterprise.